Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Glutamine in Children With Sickle Cell Anemia
NCT00131508Phase 2Terminated
- Sponsor
- St. Jude Children's Research Hospital
- Start
- May 2004
- Primary completion
- Apr 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in sickle cell anemia (SCA) comparing Glutamine with Placebo (2 arms). Primary endpoint: Change in Resting Energy Expenditure at 12 months. Started May 2004; status: terminated.
02
Drugs
glutamine
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT00131508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00131508.